Congress of psychiatry

08:15 – 09:45
 | 
Room R3
TOPIC 2:
 Mental disorders due to psychotropic 
substances, behavioural addictions
Substance abuse and behavioral addictions
Chairs: 
Susumu Higuchi, Japan 
Tagrid Leménager, Germany
001
  Excessive smartphone use and mental health: 
the impact of extreme mediation on psychosocial 
wellness
Anthony Faiola, USA
Preethi Srinivas
002
  Determinants  of internet addictions in Portu-
guese academic population – autistic traits, coping 
mechanisms and sociodemographic variables
Patrick Alexandre Barbosa Alves, Portugal
Eduardo Palha Fernandes, Cristina Sousa
003
  Smartphone and internet addiction in school 
going children and associated psychopathologies
Awadhesh P. Singh Solanki, India
004
  Internet addiction among medical students of 
Sohaug University, Egypt
Hanan Aly, Egypt
Rasha Ali, Nesreen Mohammed

MOND
A
Y
TUESD
A
Y
WEDNESD
A
Y
THURSD
A
Y
84
SCIENTIFIC
 PROGRAMME
OS-04 
Oral Presentation Session
08:15 – 09:45
 | 
Room R13
TOPIC 17:
 Psychotherapy
Psychotherapeutical interventions I
Chairs: 
Daniel Nahum, USA 
Michael Linden, Germany
001
  Impact of therapist change after initial contact 
and traumatic burden on dropout in a naturalistic 
sample of inpatients with borderline pathology 
receiving dialectical behavior therapy
Carolin Steuwe, Germany
Michaela Berg, Martin Driessen, Thomas Beblo
002
  Development and preliminary evaluation of 
manual-based group intensive outpatient program 
(M-IOP) for patients with bipolar disorders in China
Xia Sun, People's Republic of China
Chengmei Yuan, Yiru Fang, Chenyu Ye, Yu Wang,  
Yong Wang, Jia Huang, Rui Song, Lili Xue, Weihong Lu, 
Zhiguo Wu, Danping Wu
003
  PTSD symptom profiles and NET treatment for 
refugee children and adolescents resettled in Canada: 
results from a randomized controlled trial
Anne Mantini, Canada
Morton Beiser, Vasanthi Srinivasan, Patricia O'Campo
004
  Exposure therapy for obsessive-compulsive 
disorder – rethinking the theory / insights from 
inhibitory learning theory
Christian Stierle, Germany
005
  Treatment of patients with fear of driving 
following a traffic accident by a virtual reality expo-
sure therapy in a driving simulator – a pilot study 
funded by the DGUV (FR232)
Yvonne Kaussner, Germany
Stefanie Schoch, Ramona Baur, Sonja Hoffmann,  
Petra Markel, Anna Kuraszkiewicz, Paul Pauli
OS-05 
Oral Presentation Session
08:15 – 09:45
 | 
Room Lindau 5
TOPIC 3:
 Psychotic disorders
Psychotic disorders I
Chairs: 
Christoph Correll, USA 
Alkomiet Hasan, Germany
001
  Modified cognitive behavioral therapy for 
elderly patients with schizophrenia – a randomized, 
controlled pilot trial
Bernhard W. Müller, Germany
Christian Kärgel, Magdalena Horacek, Ute Darrelmann, 
Imma Fischer, Anja Heger, Daniela Kariofillis, Beate 
Nentwich, Christoph Meisner, Claudia Ose, Svenja 
Unsöld, Jens Wiltfang, Michael Wagner, Stefan 
Klingberg, Gudrun Sartory
002
  Antipsychotic augmentation vs. monotherapy 
in schizophrenia: systematic review, meta-analysis 
and metaregression analysis
Britta Galling, Germany
Christoph Correll
003
  Adjuvant Aspirin therapy in schizophrenia: 
randomized, placebo controlled trial
Amina Aissa, Tunisia
Arij Ben Chaabene, Amine Larnaout, Kaouther Ben 
Neticha, Ben Ammar Hanene, Emira Khelifa, Fayza Ayari, 
Ryad Tamouza, Fethi Guemira, Zouhaier El Hechmi
004
  Vitamin D and schizophrenia: state of the art
Lígia Castanheira, Portugal
Carla Ferreira, Liliana Ferreira, João Miguel Pereira
005
  Efficacy and safety of MIN-101: a new drug for 
the treatment of negative symptoms in schizophrenia 
– a 12-week randomized, double blind, placebo- 
controlled trial
Michael Davidson, Israel
Remy Luthringer, Jay Saoud, Corinne Staner
006
  Predictors of non-adherence to medication 
among patients with schizophrenia
Babatunde Fadipe, Nigeria
Timothy Adebowale, Andrew Olagunju, Adegboyega 
Ogunwale
OS-06 
Oral Presentation Session
08:15 – 09:45
 | 
Room R6
TOPIC 23:
 Health care research and models, health care 
policy
Health care models and services I
Chairs: 
Virginia Rosabal, Costa Rica 
Georg Schomerus, Germany
001
  How does utilization of health care services 
change in people with dementia served by Dementia 
Care Networks in Germany? Results of the DemNet-
D-study
René Thyrian, Germany
Bernhard Michalowsky, Johannes Hertel, Markus 
Wübbeler, Bernhard Holle, Susanne Schäfer-Walkmann, 
Karin Wolf-Ostermann, Wolfgang Hoffmann
002
  Lessons learned from implementing a delir 
pathway in the preoperative setting – or what we 
think we could learn
Jutta Ernst, Switzerland
003
  Remembrance of things present
Peter Maeck, USA
004
  Achieving a high ratio of crisis resolution home 
treatment care to inpatient care in London using an 
integrated adult acute care pathway
Bill Travers, United Kingdom
Tracy Barry, Asif Bachlani, Wellington Makala

MOND
A
Y
TUESD
A
Y
WEDNESD
A
Y
THURSD
A
Y
 German language Session 
 Q & A  Modul
85
SCIENTIFIC
 PROGRAMME
005
  Developing community mental healthcare: 
Kosovo case
Naim Fanaj, Republic of Kosovo
Gani Halilaj, Fahri Drevinja, Shpend Haxhibeqiri
006
  Cost drivers of inpatient mental health care:  
a systematic review
Jan Wolff, Germany
Paul McCrone, Leonardo Koeser, Claus Normann,  
Anita Patel
OS-07 
Oral Presentation Session
08:15 – 09:45
 | 
Room R8
TOPIC 3:
 Psychotic disorders
Psychotic disorders II
Chairs: 
Silvana Galderisi, Italy 
Andreas J. Fallgatter, Germany
001
  A comparative study of self-stigma and quality 
of life of individuals with schizophrenia with or 
without diabetes mellitus in Lagos State, Nigeria
Elizabeth Campbell, Nigeria
Ogonnaya Ndupu, Mashudat Bello-Mojeed, Joseph 
Adeyemi
002
  Family perception and 6-month symptomatic 
and functioning outcomes in young adolescents at 
clinical high risk for psychosis in a general popula-
tion in China
Lu Wang, People's Republic of China
Xudong Zhao, Jingyu Shi, Fazhan Chen, Yuhong Yao
003
  Outpatient treatment in psychotic patients to 
prevent compulsory readmissions because of endan-
gering behavior
Nicole Frommann, Germany
Birgit Janssen, Christian Luckhaus, Wolfgang Gaebel
004
  Fractures, mortality and antipsychotic treatment: 
a 5 years retrospective cohort study in Catalonia
Liliana Galindo Guarín, Spain
S. Gonzalez, M. Ibarra, A. Prats, L. Viñas, G. Montero 
Gonzalez, M. Fernandez, V. Pérez-Sola
005
  Caregivers of individuals with bipolar disorder – 
what kind of support would they want for themselves?
Thomas Daniel Meyer, USA
Rebecca Casarez, Sriram Iyengar, Jair Soares
SP-02 
Special Session
08:45 – 09:45
 | 
Room  M2 / M3
TOPIC 25:
 Training and continuing education
Opening of the Early Career Psychiatrists  
Programme
Chairs: 
Arno Deister, Germany 
Fritz Hohagen, Germany
Discussants: 
Norman Sartorius, Switzerland 
Pavel Alfimov, Russia 
Livia de Picker, Belgium 
Berend Malchow, Germany 
Christian Muñoz Farías, Colombia 
Mariana Pinto da Costa, Portugal 
Oliver Schubert, Australia 
Ekin Sönmez, Turkey 
Xudong Zhao, People's Republic of China
001
  Welcome address WPA ECP Section
Hussien Elkholy, Egypt
002
  Welcome address EPA ECPC
Olga Kazakova, Belarus
003
  Welcome address EFPT
Howard Ryland, United Kingdom
004
  Welcome address DGPPN Generation PSY
Jakob Kaminski, Germany
KN-01 
Keynote Lecture
10:00 – 11:00
 | 
Hall B
 
TOPIC 36:
 Social determinants of mental health
The health gap: the challenge of an unequal world
Chairs: 
Dinesh Bhugra, United Kingdom 
Peter Falkai, Germany
Speaker: 
Sir Michael Marmot, United Kingdom
KN-02 (d) 
Keynote Lecture
10:00 – 11:00
 | 
Hall A8
 
TOPIC 23:
 Health care research and models, health care 
policy
 
Zukunft der psychiatrischen Versorgung
Chairs: 
Iris Hauth, Germany 
Andreas Heinz, Germany
Speaker: 
Arno Deister, Germany
Preisverleihung: 
DGPPN-Preis für Versorgungsforschung in Psychiatrie 
und Psychotherapie
Laudation: 
Iris Hauth, Germany

MOND
A
Y
TUESD
A
Y
WEDNESD
A
Y
THURSD
A
Y
86
SCIENTIFIC
 PROGRAMME
ME-01 Meet-the-Expert
10:00 – 11:00
 | 
Hall A2 
TOPIC 23:
 Health care research and models, health care 
policy
Global mental health: the fundamental questions
Chairs: 
Berend Malchow, Germany 
Madalina Hostiuc, Germany
Speaker: 
Graham Thornicroft, United Kingdom
ST-02 (d) 
State-of-the-Art-Symposium
10:00 – 11:30
 | 
Hall  A6 / A7
 
TOPIC 5:
 Neurotic, stress-related and somatoform 
disorders
 
Zwangsstörungen
Chairs: 
Fritz Hohagen, Germany 
Ulrich Voderholzer, Germany
001
  Psychotherapie der Zwangsstörungen
Fritz Hohagen, Germany
002
  State-of-the-Art der Pharmakotherapie bei 
Zwangsstörungen und neue therapeutische Entwick-
lungen
Ulrich Voderholzer, Germany
ST-03 (d) 
State-of-the-Art-Symposium
10:00 – 11:30
 | 
Hall A3
 
TOPIC 5:
 Neurotic, stress-related and somatoform 
disorders
 
Dissoziative Störungen
Chairs: 
Carsten Spitzer, Germany 
Kathlen Priebe, Germany
S-022 Symposium
10:00 – 11:30
 | 
Hall A5
 
TOPIC 18:
 Pharmacotherapy
Antidepressants – proof of evidence vs. critical 
reception in public
Chairs: 
Siegfried Kasper, Austria 
Hans-Jürgen Möller, Germany
001
  Efficacy of antidepressiva is well
Elias Erikson, Sweden
002
  The antidepressiva-criticism in the mass-media
Kostas Fountoulakis, Greece
003
  Ways to improve the efficacy of antidepressiva 
in non-responsive patients?
Siegfried Kasper, Austria
004
  AD or / and psychotherapy: the clinical perspective
Gerd Laux, Germany
S-023 Symposium
10:00 – 11:30
 | 
Hall A1
 
TOPIC 8:
 Disorders closely related to childhood and 
adolescence
Clinical staging in psychiatry – next steps for early 
intervention and personalized treatment
Chairs: 
Wim Veling, The Netherlands 
Patrick McGorry, Australia
001
  Prevalence and sociodemographic correlates 
of emotional disorder in an inner-city cohort: the 
Resilience, Ethnicity, and AdolesCent Mental Health 
(REACH) study
Craig Morgan, United Kingdom
002
  Psychotic experiences as marker of developing 
psychopathology in adolescence: the MasterMind 
study
Saliha El-Bouhaddani, The Netherlands
Lieke van Domburgh, Barbara Schaefer,  
Theo Doreleijers, Wim Veling
003
  Symptoms and functioning after first episode 
of psychosis – clinical staging in the Psychosis  
Recent Onset GRoningen Survey (PROGR-S)
Wim Veling, The Netherlands
Vera Brink, Catheleine van Driel, Edith Liemburg, Stynke 
Castelein
004
  The next stage of early intervention: transdiag-
nostic, personalized, universal
Patrick McGorry, Australia
S-024 Symposium
10:00 – 11:30
 | 
Hall A4
 
TOPIC 14:
 Neurobiology and genetics
Discovery of genetic signatures of mental diseases: 
approaches from top-down and from bottom-up
Chairs: 
Michael O'Donovan, United Kingdom 
Hannelore Ehrenreich, Germany
001
  PGC GWAS schizophrenia – history, state and 
future perspectives
Michael O'Donovan, United Kingdom
002
  Educational attainment GWAS as tool to  
approach biological subgroups of mental disease
Philipp Koellinger, The Netherlands
003
  Common psychiatric disorders share the same 
genetic origin – consequences for adverse outcomes
Paul Lichtenstein, Sweden
004
  OTTO: a new strategy to extract mental 
disease-relevant combinations of GWAS hits from 
individuals
Hannelore Ehrenreich, Germany

MOND
A
Y
TUESD
A
Y
WEDNESD
A
Y
THURSD
A
Y
 German language Session 
 Q & A  Modul
87
SCIENTIFIC
 PROGRAMME
S-025 Symposium
10:00 – 11:30
 | 
Hall Helsinki 1
 
TOPIC 20:
 Prevention and health promotion
Positive psychiatry: from mental illness to mental 
health
Chairs: 
Wolfgang Maier, Germany 
Michaela Amering, Austria
001
  Concepts and interventions in positive psychiatry
Martin Bohus, Germany
002
  Recovery in mental health: reshaping responsi-
bilities
Michaela Amering, Austria
003
  Successful aging
Wolfgang Maier, Germany
004
  An epigenetic signature of resilience?
Bart Rutten, The Netherlands
S-026 Symposium
10:00 – 11:30
 | 
Hall Helsinki 2
 
TOPIC 3:
 Psychotic disorders
Limbic encephalitis and immunological encephalop-
athy: a revolutionary concept for psychiatry?
›
 DGPPN Section: Neuropsychiatry
Chairs: 
Ludger Tebartz van Elst, Germany 
Josef Priller, Germany
001
  Latest insights into the function of the CNS 
immune system
Josef Priller, Germany
002
  NMDA receptor encephalitis and other antibody 
– mediated disorders of the synapse
Josep Dalmau, Spain
003
  Antibody findings in psychiatric patients:  
a critical analysis of the state-of-the-art
Angela Vincent, United Kingdom
004
  Immunological encephalopathies in psychiatry: 
clinical findings and therapeutic implications
Ludger Tebartz van Elst, Germany
S-027 Symposium
10:00 – 11:30
 | 
Hall Paris 1
 
TOPIC 9:
 Comorbidity of somatic and mental disorders, 
psychosomatics
Increased morbidity and mortality among patients 
with severe mental illness
Chairs: 
Frank Schneider, Germany 
Reinhard Heun, United Kingdom
001
  Physical comorbidity and its relevance on 
mortality in schizophrenia: a naturalistic 12-year 
follow-up in general hospital admissions
Reinhard Heun, United Kingdom
002
  Effects of antipsychotics, antidepressants and 
mood stabilizers on risk for physical diseases in  
people with severe mental illness
Christoph Correll, USA
003
  Excess deaths and mortality trends in cardio-
vascular causes of deaths in schizophrenia, bipolar 
and unipolar mood disorder in Sweden 1987 – 2010
Urban Ösby, Sweden
004
  Mortality in severe mental illness: first time 
results from statutory health insurance in Germany
Frank Schneider, Germany
Michael Erhart, Walter Hewer, Jessica Junger
S-028 Symposium
10:00 – 11:30
 | 
Hall Paris 2
 
TOPIC 16:
 Diagnostics and classification, 
psychopathology, RDoC
Motor dysfunction in schizophrenia-spectrum dis-
orders and beyond: advances, challenges and future 
directions
Chairs: 
Dusan Hirjak, Germany 
Robert Christian Wolf, Germany
001
  Does subtle motor dysfunction in healthy indi-
viduals represent a biomarker of vulnerability  
to psychosis?
Dusan Hirjak, Germany
002
  Motor dysfunction and motion energy analysis 
in ultra-high risk individuals as biomarkers of  
progression to psychosis
Tina Gupta, USA
003
  Aberrant functional connectivity within the 
motor system is linked to motor abnormalities in 
psychosis
Sebastian Walther, Switzerland
Andrea Federspiel, Katharina Stegmayer, Petra Viher
004
  Beyond schizophrenia: transnosologic aspects 
of motor dysfunction
Robert Christian Wolf, Germany

MOND
A
Y
TUESD
A
Y
WEDNESD
A
Y
THURSD
A
Y
88
SCIENTIFIC
 PROGRAMME
S-029 Symposium
10:00 – 11:30
 | 
Hall Berlin 1
 
TOPIC 32:
 Violence and trauma
Evidence-based interventions to reduce seclusion 
and restraint in psychiatric hospitals
Chairs: 
Tilman Steinert, Germany 
Anu Putkonen, Finland
001
  Reduction of coercive measures – a systematic 
review
Sophie Hirsch, Germany
002
  Six core strategies (6cs) in forensic psychiatry 
in Finland: 9 years outcome
Anu Putkonen, Finland
Satu Kuivalainen, Olavi Louheranta, Hannu Kautiainen, 
Eila Repo-Tiihonen, Kari Ojala, Jari Tiihonen
003
  Outcomes of an individualised psycho-education 
and monitoring programme to reduce compulsory 
hospitalization
Barbara Lay, Switzerland
004
  Short-term risk assessment in emergency  
psychiatry
Roland van de Sande, The Netherlands
S-030 Symposium
10:00 – 11:30
 | 
Hall Berlin 2
 
TOPIC 20:
 Prevention and health promotion
Realizing the potential of internet-based and other 
scalable interventions to improve mental health 
care and reach underserved populations
Chairs: 
Björn Meyer, Germany 
Vladimir Carli, Sweden
001
  Evaluating an e-mental health program  
(“deprexis”) as adjunctive treatment tool in psycho-
therapy for depression: first results of a pragmatic 
randomized controlled trial
Andreas Maercker, Switzerland
002
  Integrating new technologies for the prevention 
of suicide and promotion of mental health
Vladimir Carli, Sweden
003
  Evaluating a novel internet intervention for  
persons with epilepsy and depression: first results 
from the ENCODE trial
Björn Meyer, Germany
Franziska Scheibe
S-031 Symposium
10:00 – 11:30
 | 
Hall New York 1
 
TOPIC 5:
 Neurotic, stress-related and somatoform 
disorders
Stress and its impact on work-life balance and 
clinical aspects
Chairs: 
Francesco Amaddeo, Italy 
Michael Sadre-Chirazi-Stark, Germany
001
  A dark triangle: stress, burnout and disability
Wolfgang Linden, Canada
002
  New approaches to technically measure the 
degree of burnout
Michael Sadre-Chirazi-Stark, Germany
003
  Quality of working life, compassion fatigue and 
burnout among mental health workers: findings 
from a multicentre study in Italy
Gaia Cetrano, United Kingdom
004
  Professional quality of life in mental health 
staff: associations with individual and occupational 
characteristics
Francesco Amaddeo, Italy